Bioavailability Normalization

Bioavailability Normalization is a methodological framework in pharmacokinetics that standardizes drug exposure measures across individuals or formulations by adjusting for differences in the rate and extent of active drug reaching the systemic circulation.

5

Publications

191

Citations

26

Authors

14

Institutions

Publications per year

2017–2026

2

Authors

26

  1. RB
    Rémy Burcelin

    Inserm, France

    1 publications · 91 citations

    1

    h-index

  2. RF
    Raphaëlle Fanciullino

    Aix-Marseille Université, France

    1 publications · 91 citations

    1

    h-index

  3. JC
    Joseph Ciccolini

    Aix-Marseille Université, France

    1 publications · 91 citations

    1

    h-index

  4. JS
    Jean‐François Savouret

    Inserm, France

    1 publications · 91 citations

    1

    h-index

  5. TY
    Tingyu Yang

    Huazhong University of Science and Technology, China

    1 publications · 18 citations

    1

    h-index

1–5 of 26

Venues

  1. 1

    h-index

  2. Drug Information Journal

    DIA · 1 publications · 52 citations

    1

    h-index

  3. Environmental Toxicology and Chemistry

    1 publications · 14 citations

    1

    h-index

  4. Frontiers in Microbiology

    1 publications · 18 citations

    1

    h-index

  5. Biochimie

    1 publications · 91 citations

    1

    h-index

1–5